Frederick biotechnology firm Veralox Therapeutics has raised a $5.4 million seed round of funding, to help push its first drug candidate toward clinical trials. The round was led by the JDRF T1D Fund, a venture fund dedicated to accelerating tech to treat, prevent and cure type 1 diabetes (T1D). well as Massachusetts-based Sanofi Ventures, and the VTC Innovation and VTC Seed Fund. The University System of Maryland’s Momentum Fund, the University of Vermont Health Network and Maryland Technology…
from https://www.bizjournals.com/baltimore/news/2019/09/05/frederick-biotech-veralox-therapeutics-raises-5-4.html?ana=RSS&s=article_search
via https://baltimorecheckbook.tumblr.com/post/187516321892
No comments:
Post a Comment